Benjamin Kelemen (@ben_kelemen) 's Twitter Profile
Benjamin Kelemen

@ben_kelemen

Interventional and critical care cardiologist. Midwest transplant to SF via Baltimore. Enjoys runs in Marin. Tweets are my own.

ID: 1242938425365295104

calendar_today25-03-2020 22:16:38

1,1K Tweet

623 Takipçi

501 Takip Edilen

Benjamin Hibbert (@benhibbertmdphd) 's Twitter Profile Photo

Matthew Sample 100% of anything probably isn’t appropriate. If you can’t offer patients radial because you don’t have that skill set - it’s time and your lab needs to address that. If you’re 100% radial and you don’t have the ability to safely access a femoral - it’s time and your lab needs to

UCSF Cardiology (@ucsfcardiology) 's Twitter Profile Photo

.Interventional Cardiology at Fort Miley was the 1st VA site in the #US to treat a patient using Boston Scientific’s AGENT Paclitaxel drug-coated balloon (DCB) to treat in-stent restenosis. Dr. Jeffrey Zimmet worked with fellows Rahul Goli & Nicky Herrick during the procedure. Joseph Yang Evelyn J. Song

.<a href="/ftmileycathlab/">Interventional Cardiology at Fort Miley</a> was the 1st VA site in the #US to treat a patient using Boston Scientific’s AGENT Paclitaxel drug-coated balloon (DCB) to treat in-stent restenosis. Dr. <a href="/jeffreyzimmet/">Jeffrey Zimmet</a> worked with fellows <a href="/goli_rahul/">Rahul Goli</a> &amp; Nicky Herrick during the procedure. <a href="/jlyang5/">Joseph Yang</a> <a href="/EvelynSongMD/">Evelyn J. Song</a>
Dr. Bill Lombardi (@drbilllombardi) 's Twitter Profile Photo

Discover how being coachable, resilient, and committed to continuous improvement on the D1 Tennis Courts helped Dr. Eric Rothstein thrive in high-pressure environments in the Cath Lab. 🌟 #Inspiration #Resilience

Discover how being coachable, resilient, and committed to continuous improvement on the D1 Tennis Courts helped Dr. Eric Rothstein thrive in high-pressure environments in the Cath Lab.

🌟 #Inspiration #Resilience
Javid Moslehi (@cardiooncology) 's Twitter Profile Photo

Congrats 2 Mandar Aras, MD, PhD for his promotion to Associate Professor UCSF Cardiology! Mandar leads our amyloid program in the Section of #CardioOnc & Immunology! Lots of developments in amyloidosis. Looking forward to #ESC2024 for new treatments being announced!

Congrats 2 <a href="/MandarArasMD/">Mandar Aras, MD, PhD</a> for his promotion to Associate Professor <a href="/UCSFCardiology/">UCSF Cardiology</a>! Mandar leads our amyloid program in the Section of #CardioOnc &amp; Immunology! Lots of developments in amyloidosis. Looking forward to #ESC2024 for new treatments being announced!
Gaurang Vaidya (@gaurang_md) 's Twitter Profile Photo

Happy to share a patent pending! Looking for collaborators to take it further.. patents.google.com/patent/US20240… A wearable doppler device to get automated blood pressure, especially for #LVAD patients. #CardioTwitter #Innovation #MedTech #medtwitter #HealthcareInnovation #Trending

Happy to share a patent pending! Looking for collaborators to take it further..
patents.google.com/patent/US20240…
A wearable doppler device to get automated blood pressure, especially for #LVAD patients.
#CardioTwitter #Innovation #MedTech #medtwitter #HealthcareInnovation #Trending
David J. Cohen, MD, MSc (@djc795) 's Twitter Profile Photo

Navin Kapur Sunil V. Rao Jason N. Katz And if one accepts that logic, then it’s equally critical for the tertiary/quartenary center to have an “open door” transfer policy— much like many do for STEMI. Otherwise, we are doomed to fail.

Khurram Nasir (@khurramn1) 's Twitter Profile Photo

#1 Exciting news! A new sham trial evaluating role of PVI in AFib prevention is making headlines👇 Big win for evidence-based medicine! But, let me take an unpopular stance for a moment Was a sham-controlled trial EVEN NECESSARY for this study? 🤔 jamanetwork.com/journals/jama/…

Rohan Kalathiya, MD (@rohankalmd) 's Twitter Profile Photo

John Mandrola, MD I am not an oncologist but when the median overall survival is 17 months with standard of care, additional 3 months is clinically significant. If QOL is maintained, this can mean a lot more meaningful life moments for patients.

Javid Moslehi (@cardiooncology) 's Twitter Profile Photo

Proud to announce the creation of the UCSF Pericarditis Center led by Alan Baik! Great addition to UCSF Cardiology Section of #CardioOnc & Immunology! Website made by UCSF Department of Medicine PGY2 resident extraordinaire Aishwarya Nene, MD MPhil! Bob Wachter Mandar Aras, MD, PhD ucsfhealthcardiology.ucsf.edu/patient-care/c…

Ajar Kochar (@ajar_kochar) 's Twitter Profile Photo

#InterventionalCardiology Fellows in NE Don’t miss the SCAI FIRST fellows edu event Tomorrow September 19 (1830) on high-risk complex #PCI. @ Del Frisco's Double Eagle Steakhouse (back bay, 888 Bolyston Street, Boston) ➡️ Register Now: scaipro.scai.org/URL/SF-Boston-…

Andrew SP Sharp (@drandrewsharp) 's Twitter Profile Photo

curzen For PCI to work, we have to define the lesion at risk with high specificity. For medical intensification to work, we have to define the patient at risk. The latter seems easier to do than the former.

Robert W. Yeh (@rwyeh) 's Twitter Profile Photo

Truly unique clinical and investigative leadership opportunity here at BIDMC CVI and BIDMC Smith Center. We are interviewing visionary leaders in the field of structural heart intervention.

Javid Moslehi (@cardiooncology) 's Twitter Profile Photo

Great spotlight on Amir Munir! Dr. Munir completed #CardioOnc fellowship at UCSF Cardiology & just joined our faculty. He has been identifying novel mediators of myocarditis including chemokine receptors! Sarnoff Foundation UCSF Helen Diller Family Comprehensive Cancer Ctr ucsfhealthcardiology.ucsf.edu/facstaff/spotl…

M. Bolton (@5_utr) 's Twitter Profile Photo

Anthony DiGiorgio, DO, MHA If you start from a place of “in what world does a government run bureaucracy operate more efficient than a private market” you end at “Medicaid only appears more efficient” and “that’s just their admin budget” 😒 Circular ⭕️ logic again…

Harun Kundi, MD, MMSc (@harunkundi) 's Twitter Profile Photo

📢 Our new study is out in JACC Journals 🔍 In patients aged 65 and older undergoing SAVR, nearly 50% undergo concomitant procedures, which are associated with increased short- and long-term mortality. 👉 jacc.org/doi/10.1016/j.… #TAVR Cardiovascular Research Foundation David J. Cohen, MD, MSc Jeffrey Popma

Andrea Elliott (@andreaelliottum) 's Twitter Profile Photo

Two Beats, One Heart 🫀 1 yr HF → 1 yr Critical Care OR 1 yr Critical Care → 1 yr Interventional ✅ Guaranteed 2nd fellowship ✅ No relocation, no hassle ✅ Board eligible for both specialties The ONLY dual-tracks fully in Cardiology!